Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +3.04% dropped 0.57% to $163.81 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.63% falling 1.70% to 4,357.73 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.48% falling 1.78% to 33,970.47. This was the stock's third consecutive day of losses. Johnson & Johnson closed $16.11 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -0.19% fell 0.90% to $362.50, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +2.32% rose 0.35% to $71.93, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.77% rose 0.71% to $44.20. Trading volume (7.2 M) eclipsed its 50-day average volume of 5.7 M.